Reahealth

北京中研海康科技有限公司是一家专注于女性乳腺健康领先企业，成立于2014年，总部位于中国北京。公司以创新医疗技术为核心，致力于改善乳腺疾病筛查、诊断和治疗，尤其在乳腺专科建设领域具有显著影响力。全球乳腺诊断、治疗设备的领导者，主打产品包括：数字乳腺机、乳腺电刺激治疗仪、乳腺激光治疗仪、乳腺熏蒸治疗仪、乳腺导管内窥镜、乳腺标本摄影系统等等。

公司集“乳腺专业精密医疗设备研发生产与销售、临床技术科研与培训、乳腺专业学科建设与运营指导”为一体的高科技企业。企业秉承“为用户提供高质量产品解决痛点难点从而创造社会效益、为合作医疗机构建设专业学科打造专业品牌、为临床医师提供专业技术培训造就专科名医、为乳腺疾病患者切实解除疾病伤害及痛苦、为企业员工搭建施展才华平台实现价值、为市场合作伙伴拓展发展空间实现满意经济效益”的宗旨，在激烈的市场竞争中脱颖而出，2017年被北京市科委授予“高新技术企业”，2020年获得北京市《新技术新产品证书》并被中关村科技园区管委会认定为“金种子企业”，2022年北京“专精特新”企业。2024年获得中国先进制造业与现代服务业试点单位。

Beijing Reahealth Technology Co., Ltd. is a leading enterprise specializing in women’s breast health. Founded in 2014 and headquartered in Beijing, China, the company focuses on innovative medical technologies to improve breast disease screening, diagnosis, and treatment. It has a significant influence in the construction of specialized breast medical departments.

As a global leader in breast diagnosis and treatment equipment, the company’s main products include:

• Digital mammography machines
• Breast electrical stimulation therapy devices
• Breast laser treatment devices
• Breast steaming therapy devices
• Breast duct endoscopes
• Breast specimen imaging systems, and more

Reahealth integrates the R&D, production, and sales of specialized breast medical equipment, clinical research and training, and professional discipline construction and operation into a high-tech enterprise.

The company upholds the mission of:

• Providing high-quality products to solve challenges and create social value
• Assisting medical institutions in building specialized departments and brands
• Offering professional technical training for clinicians to nurture top specialists
• Relieving breast disease patients from pain and suffering
• Creating a platform for employees to showcase their talents
• Expanding opportunities for market partners to achieve economic benefits

Through fierce market competition, the company has stood out and received multiple honors:

• 2017: Recognized as a “High-Tech Enterprise” by the Beijing Science and Technology Commission
• 2020: Awarded the “New Technology and New Product Certificate” and recognized as a “Golden Seed Enterprise” by the Zhongguancun Science Park
• 2022: Named a “Specialized and Innovative” Enterprise in Beijing
• 2024: Selected as a pilot unit for China’s Advanced Manufacturing and Modern Service Industry Integration

Key Milestones

• First Entrepreneurial Venture (2005)
  • Established Beijing Healthcome
  • Independently developed China’s first high-frequency mammography machine
• Acquisition by a U.S. Company (2010)
  • Beijing Healthcome’s molybdenum target digital mammography machine was acquired by U.S. medical giant Hologic
  • Launched China’s first tungsten target digital mammography machine
• Second Entrepreneurial Venture (2015)
  • Founded Beijing Reahealth
  • Developed China’s first amorphous selenium tungsten target digital mammography machine
  • First domestic company to sign agreements with hospitals to co-operate in breast department construction
• Mass Production of Amorphous Selenium Digital Mammography Machine (2019)
  • Obtained production license and began sales
  • Successfully implemented breast department construction in over 100 hospitals
• Recognitions and Growth
  • 2020: Recognized as a “Golden Seed Enterprise” by Zhongguancun, awarded the “New Technology & New Product Certificate”
  • 2022: Named in the second batch of Beijing’s “Specialized and Innovative” Enterprises
  • 2024: Selected as one of Beijing’s first city-level integration pilot enterprises

The company has also obtained certifications, including ISO 9001 System Certification and Service Credibility System Certification.

Research & Development Center

The company operates a 1,000-square-meter R&D and production center with cutting-edge technology, intellectual property rights, and a dedicated innovation team to drive advancements in medical devices.